JP4975745B2 - Ｋｓｐインヒビターとしての置換イミダゾール化合物 - Google Patents

Info

Publication number

JP4975745B2

JP4975745B2 JP2008526175A JP2008526175A JP4975745B2 JP 4975745 B2 JP4975745 B2 JP 4975745B2 JP 2008526175 A JP2008526175 A JP 2008526175A JP 2008526175 A JP2008526175 A JP 2008526175A JP 4975745 B2 JP4975745 B2 JP 4975745B2

Authority

JP

Japan

Prior art keywords

phenyl

benzyl

imidazol

amino

fluoro

Prior art date

2005-08-09

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• Discuss

• 239000003112 inhibitor Substances 0.000 title description 8
• 150000002460 imidazoles Chemical class 0.000 title description 3
• 150000001875 compounds Chemical class 0.000 claims description 184
• -1 carboxyl ester Chemical class 0.000 claims description 167
• 125000000623 heterocyclic group Chemical group 0.000 claims description 119
• 125000001072 heteroaryl group Chemical group 0.000 claims description 78
• 125000000217 alkyl group Chemical group 0.000 claims description 53
• 125000003118 aryl group Chemical group 0.000 claims description 52
• 239000001257 hydrogen Substances 0.000 claims description 48
• 229910052739 hydrogen Inorganic materials 0.000 claims description 48
• 125000003107 substituted aryl group Chemical group 0.000 claims description 45
• 238000000034 method Methods 0.000 claims description 37
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 33
• 125000000547 substituted alkyl group Chemical group 0.000 claims description 32
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 30
• 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 27
• 229910052757 nitrogen Inorganic materials 0.000 claims description 26
• 125000003342 alkenyl group Chemical group 0.000 claims description 23
• 150000003839 salts Chemical class 0.000 claims description 20
• 125000000304 alkynyl group Chemical group 0.000 claims description 19
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 18
• 125000004432 carbon atom Chemical group C* 0.000 claims description 18
• 125000005843 halogen group Chemical group 0.000 claims description 18
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 16
• 125000004433 nitrogen atom Chemical group N* 0.000 claims description 15
• 125000005017 substituted alkenyl group Chemical group 0.000 claims description 15
• 125000004426 substituted alkynyl group Chemical group 0.000 claims description 15
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 14
• 125000003545 alkoxy group Chemical group 0.000 claims description 13
• 229910052799 carbon Inorganic materials 0.000 claims description 13
• 125000004442 acylamino group Chemical group 0.000 claims description 12
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 12
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 12
• 125000005415 substituted alkoxy group Chemical group 0.000 claims description 11
• 239000004202 carbamide Substances 0.000 claims description 10
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 9
• 125000000266 alpha-aminoacyl group Chemical group 0.000 claims description 8
• 125000004429 atom Chemical group 0.000 claims description 8
• 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 7
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 7
• 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 6
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
• 125000001309 chloro group Chemical group Cl* 0.000 claims description 6
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 6
• 125000001153 fluoro group Chemical group F* 0.000 claims description 6
• IVXQBCUBSIPQGU-UHFFFAOYSA-N piperazine-1-carboxamide Chemical compound NC(=O)N1CCNCC1 IVXQBCUBSIPQGU-UHFFFAOYSA-N 0.000 claims description 6
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
• 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 4
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
• MYELFCBDZMZCFZ-QFIPXVFZSA-N 1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-1,3-diazinan-2-one Chemical compound N1([C@H](C(C)(C)C)C=2N(C=C(N=2)C=2C=CC=CC=2)CC=2C=CC=CC=2)CCCNC1=O MYELFCBDZMZCFZ-QFIPXVFZSA-N 0.000 claims description 3
• 125000002947 alkylene group Chemical group 0.000 claims description 3
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 3
• ZNKDSAAYZDEZAY-RDKKHIPBSA-N n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-n-[[(3r,4r)-4-hydroxypyrrolidin-3-yl]methyl]-4-piperidin-1-ylpiperidine-1-carboxamide Chemical compound C1CC(N2CCCCC2)CCN1C(=O)N([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C[C@H]1CNC[C@@H]1O ZNKDSAAYZDEZAY-RDKKHIPBSA-N 0.000 claims description 3
• QEDIQYPGKNETBN-WNOXWKSXSA-N n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-n-[[(3s)-3-fluoropyrrolidin-3-yl]methyl]-4-piperidin-1-ylpiperidine-1-carboxamide Chemical compound C1CC(N2CCCCC2)CCN1C(=O)N([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C[C@]1(F)CCNC1 QEDIQYPGKNETBN-WNOXWKSXSA-N 0.000 claims description 3
• ZNKDSAAYZDEZAY-ZVPJJTBRSA-N n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-n-[[(3s,4s)-4-hydroxypyrrolidin-3-yl]methyl]-4-piperidin-1-ylpiperidine-1-carboxamide Chemical compound C1CC(N2CCCCC2)CCN1C(=O)N([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C[C@@H]1CNC[C@H]1O ZNKDSAAYZDEZAY-ZVPJJTBRSA-N 0.000 claims description 3
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
• 125000006833 (C1-C5) alkylene group Chemical group 0.000 claims description 2
• 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 2
• 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
• 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 claims description 2
• 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 2
• 125000004212 difluorophenyl group Chemical group 0.000 claims description 2
• 150000002431 hydrogen Chemical class 0.000 claims 12
• WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims 11
• 125000004356 hydroxy functional group Chemical group O* 0.000 claims 9
• 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 5
• RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 claims 2
• LCDCPQHFCOBUEF-UHFFFAOYSA-N pyrrolidine-1-carboxamide Chemical compound NC(=O)N1CCCC1 LCDCPQHFCOBUEF-UHFFFAOYSA-N 0.000 claims 2
• ZGGXJHGNKKKHOC-CWSACCBASA-N (2r,6s)-n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-[(3-hydroxyphenyl)methyl]-4-(2,3,5-trifluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-2,6-dimethylmorpholine-4-carboxamide Chemical compound C1[C@@H](C)O[C@@H](C)CN1C(=O)N(CC[C@H](N)CF)[C@H](C(C)(C)C)C1=NC(C=2C(=C(F)C=C(F)C=2)F)=CN1CC1=CC=CC(O)=C1 ZGGXJHGNKKKHOC-CWSACCBASA-N 0.000 claims 1
• IJSPTPUFPQCSPT-CAVYSCNFSA-N (2s)-n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-2-(hydrazinecarbonyl)pyrrolidine-1-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCC[C@H]1C(=O)NN IJSPTPUFPQCSPT-CAVYSCNFSA-N 0.000 claims 1
• FAIUWKXDSLBIKT-FFBVMRPSSA-N (2s,6r)-n-[(3r)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-2,6-dimethylmorpholine-4-carboxamide Chemical compound C1[C@@H](C)O[C@@H](C)CN1C(=O)N(CC[C@@H](N)CF)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 FAIUWKXDSLBIKT-FFBVMRPSSA-N 0.000 claims 1
• FAIUWKXDSLBIKT-XGBDYCOJSA-N (2s,6r)-n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-2,6-dimethylmorpholine-4-carboxamide Chemical compound C1[C@@H](C)O[C@@H](C)CN1C(=O)N(CC[C@H](N)CF)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 FAIUWKXDSLBIKT-XGBDYCOJSA-N 0.000 claims 1
• CSLRISDYBRAABM-UHFFFAOYSA-N (3,5-dimethyl-1,2-oxazol-4-yl)urea Chemical compound CC1=NOC(C)=C1NC(N)=O CSLRISDYBRAABM-UHFFFAOYSA-N 0.000 claims 1
• JHYXLHFINQYNSP-CVWIZFJUSA-N (3r)-n-(3-amino-2-fluoropropyl)-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-hydroxypiperidine-1-carboxamide Chemical compound NCC(F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N1CCC[C@@H](O)C1 JHYXLHFINQYNSP-CVWIZFJUSA-N 0.000 claims 1
• AXZRSNIRYBQWBV-VPUSJEBWSA-N (3r)-n-(3-aminopropyl)-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-hydroxypiperidine-1-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N1CCC[C@@H](O)C1 AXZRSNIRYBQWBV-VPUSJEBWSA-N 0.000 claims 1
• GEBYXLCXSRCDDD-RSXGOPAZSA-N (3r)-n-(3-aminopropyl)-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N1CC[C@@H](O)C1 GEBYXLCXSRCDDD-RSXGOPAZSA-N 0.000 claims 1
• UBUFNHIDNFICAK-MZKUHISZSA-N (3r)-n-[(2r)-3-amino-2-fluoropropyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N1CC[C@@H](O)C1 UBUFNHIDNFICAK-MZKUHISZSA-N 0.000 claims 1
• JXADZOUBCXDJMD-OBTVHEKISA-N (3r)-n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CC[C@@H](O)C1 JXADZOUBCXDJMD-OBTVHEKISA-N 0.000 claims 1
• YRIWIRWRACZCEV-WEWMWRJBSA-N (3r)-n-[(3s)-3-amino-4-hydroxybutyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound OC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N1CC[C@@H](O)C1 YRIWIRWRACZCEV-WEWMWRJBSA-N 0.000 claims 1
• GEBYXLCXSRCDDD-AHWVRZQESA-N (3s)-n-(3-aminopropyl)-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N1CC[C@H](O)C1 GEBYXLCXSRCDDD-AHWVRZQESA-N 0.000 claims 1
• JHYXLHFINQYNSP-OBDYRVMHSA-N (3s)-n-[(2r)-3-amino-2-fluoropropyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-hydroxypiperidine-1-carboxamide Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N1CCC[C@H](O)C1 JHYXLHFINQYNSP-OBDYRVMHSA-N 0.000 claims 1
• UBUFNHIDNFICAK-USZFVNFHSA-N (3s)-n-[(2r)-3-amino-2-fluoropropyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N1CC[C@H](O)C1 UBUFNHIDNFICAK-USZFVNFHSA-N 0.000 claims 1
• JXADZOUBCXDJMD-WCYRKSIYSA-N (3s)-n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CC[C@H](O)C1 JXADZOUBCXDJMD-WCYRKSIYSA-N 0.000 claims 1
• ACBMLNDOSAGHMQ-OYRHQHFDSA-N (4r)-n-[(2r)-3-amino-2-fluoropropyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-4-hydroxy-1,2-oxazolidine-2-carboxamide Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N1C[C@@H](O)CO1 ACBMLNDOSAGHMQ-OYRHQHFDSA-N 0.000 claims 1
• YJAJCWNCASSMCP-WKDCXCOVSA-N 1-(3-amino-2-fluoropropyl)-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(oxan-4-yl)urea Chemical compound NCC(F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1CCOCC1 YJAJCWNCASSMCP-WKDCXCOVSA-N 0.000 claims 1
• RZXWYROYFAABBQ-VWLOTQADSA-N 1-(3-amino-3-methylbutyl)-1-[(1r)-1-[1-benzyl-4-(3-fluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3,3-dimethylurea Chemical compound CC(N)(C)CCN(C(=O)N(C)C)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC=C1 RZXWYROYFAABBQ-VWLOTQADSA-N 0.000 claims 1
• UHUXHUKWWQFRCE-DEOSSOPVSA-N 1-(3-amino-3-methylbutyl)-1-[(1r)-1-[1-benzyl-4-(3-fluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-methylurea Chemical compound CC(N)(C)CCN(C(=O)NC)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC=C1 UHUXHUKWWQFRCE-DEOSSOPVSA-N 0.000 claims 1
• UOJMAYSKJKNYQX-QHCPKHFHSA-N 1-(3-amino-3-methylbutyl)-1-[(1r)-1-[1-benzyl-4-(3-fluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]urea Chemical compound CC(C)(N)CCN(C(N)=O)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC=C1 UOJMAYSKJKNYQX-QHCPKHFHSA-N 0.000 claims 1
• JHUBDJRPIBVVOT-DEOSSOPVSA-N 1-(3-aminopropyl)-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3,3-dimethylurea Chemical compound NCCCN(C(=O)N(C)C)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 JHUBDJRPIBVVOT-DEOSSOPVSA-N 0.000 claims 1
• YLZAOVGOLHWUIP-MHZLTWQESA-N 1-(3-aminopropyl)-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(2,6-dichloropyridin-4-yl)urea Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1=CC(Cl)=NC(Cl)=C1 YLZAOVGOLHWUIP-MHZLTWQESA-N 0.000 claims 1
• CMVBTIQUWLAFGG-VWLOTQADSA-N 1-(3-aminopropyl)-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(2-methoxyethyl)urea Chemical compound COCCNC(=O)N(CCCN)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 CMVBTIQUWLAFGG-VWLOTQADSA-N 0.000 claims 1
• GVROZXWSBGMVFV-LJAQVGFWSA-N 1-(3-aminopropyl)-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(4-cyanophenyl)urea Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1=CC=C(C#N)C=C1 GVROZXWSBGMVFV-LJAQVGFWSA-N 0.000 claims 1
• DZFBZDXQJDMOQL-MHZLTWQESA-N 1-(3-aminopropyl)-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(furan-2-ylmethyl)urea Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NCC1=CC=CO1 DZFBZDXQJDMOQL-MHZLTWQESA-N 0.000 claims 1
• QQIWLVZSEFYAKN-QFIPXVFZSA-N 1-(3-aminopropyl)-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-hydroxyurea Chemical compound NCCCN(C(=O)NO)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 QQIWLVZSEFYAKN-QFIPXVFZSA-N 0.000 claims 1
• YVAASELBMSWLMT-QHCPKHFHSA-N 1-(3-aminopropyl)-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-methylurea Chemical compound NCCCN(C(=O)NC)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 YVAASELBMSWLMT-QHCPKHFHSA-N 0.000 claims 1
• KAYKZMXGMYYSGB-NDEPHWFRSA-N 1-(3-aminopropyl)-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-phenylurea Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1=CC=CC=C1 KAYKZMXGMYYSGB-NDEPHWFRSA-N 0.000 claims 1
• RQRGEDRGKIMIJF-SANMLTNESA-N 1-(3-aminopropyl)-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-thiophen-2-ylurea Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1=CC=CS1 RQRGEDRGKIMIJF-SANMLTNESA-N 0.000 claims 1
• HPNQEBZUAHRBND-SANMLTNESA-N 1-(3-aminopropyl)-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-thiophen-3-ylurea Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC=1C=CSC=1 HPNQEBZUAHRBND-SANMLTNESA-N 0.000 claims 1
• PVYDRBCTJXWSNM-DEOSSOPVSA-N 1-(3-aminopropyl)-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3,3-dimethylurea Chemical compound NCCCN(C(=O)N(C)C)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 PVYDRBCTJXWSNM-DEOSSOPVSA-N 0.000 claims 1
• RVDVXHZKWMWYEP-QHCPKHFHSA-N 1-(3-aminopropyl)-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-methylurea Chemical compound NCCCN(C(=O)NC)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 RVDVXHZKWMWYEP-QHCPKHFHSA-N 0.000 claims 1
• PKAHTZGPEBWADF-NGQVCNFZSA-N 1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-1-[(3s)-3-(1,3-dioxoisoindol-2-yl)-4-fluorobutyl]-3-methylurea Chemical compound C1([C@H](N(CC[C@@H](CF)N2C(C3=CC=CC=C3C2=O)=O)C(=O)NC)C(C)(C)C)=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 PKAHTZGPEBWADF-NGQVCNFZSA-N 0.000 claims 1
• CTKJAAYFBLEFDU-VWNXMTODSA-N 1-[(2r)-3-amino-2-fluoropropyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3,3-dimethylurea Chemical compound NC[C@@H](F)CN(C(=O)N(C)C)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 CTKJAAYFBLEFDU-VWNXMTODSA-N 0.000 claims 1
• DRQWOIWQLWVPNS-NOZRDPDXSA-N 1-[(2r)-3-amino-2-fluoropropyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(2-hydroxyethyl)-3-methylurea Chemical compound OCCN(C)C(=O)N(C[C@H](F)CN)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 DRQWOIWQLWVPNS-NOZRDPDXSA-N 0.000 claims 1
• DWRXANOIMWBODT-NOZRDPDXSA-N 1-[(2r)-3-amino-2-fluoropropyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(2-methoxyethyl)urea Chemical compound COCCNC(=O)N(C[C@H](F)CN)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 DWRXANOIMWBODT-NOZRDPDXSA-N 0.000 claims 1
• NVCALJIXJGLXDS-LXFBAYGMSA-N 1-[(2r)-3-amino-2-fluoropropyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(3,4-difluorophenyl)urea Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1=CC=C(F)C(F)=C1 NVCALJIXJGLXDS-LXFBAYGMSA-N 0.000 claims 1
• FBBVYHJYFRJSFO-UHSQPCAPSA-N 1-[(2r)-3-amino-2-fluoropropyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(4-cyanophenyl)urea Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1=CC=C(C#N)C=C1 FBBVYHJYFRJSFO-UHSQPCAPSA-N 0.000 claims 1
• YJAJCWNCASSMCP-SQHAQQRYSA-N 1-[(2r)-3-amino-2-fluoropropyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(oxan-4-yl)urea Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1CCOCC1 YJAJCWNCASSMCP-SQHAQQRYSA-N 0.000 claims 1
• JZHHUYAASSIIBG-NAKRPHOHSA-N 1-[(2r)-3-amino-2-fluoropropyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-phenylurea Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1=CC=CC=C1 JZHHUYAASSIIBG-NAKRPHOHSA-N 0.000 claims 1
• SQOOSPQLXLEPKM-BVAGGSTKSA-N 1-[(2r)-3-amino-2-fluoropropyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-thiophen-3-ylurea Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC=1C=CSC=1 SQOOSPQLXLEPKM-BVAGGSTKSA-N 0.000 claims 1
• FBBVYHJYFRJSFO-WNJJXGMVSA-N 1-[(2s)-3-amino-2-fluoropropyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(4-cyanophenyl)urea Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1=CC=C(C#N)C=C1 FBBVYHJYFRJSFO-WNJJXGMVSA-N 0.000 claims 1
• JZHHUYAASSIIBG-LSYYVWMOSA-N 1-[(2s)-3-amino-2-fluoropropyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-phenylurea Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1=CC=CC=C1 JZHHUYAASSIIBG-LSYYVWMOSA-N 0.000 claims 1
• SQOOSPQLXLEPKM-OZXSUGGESA-N 1-[(2s)-3-amino-2-fluoropropyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-thiophen-3-ylurea Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC=1C=CSC=1 SQOOSPQLXLEPKM-OZXSUGGESA-N 0.000 claims 1
• PRXTZIHOAREPRY-UNMCSNQZSA-N 1-[(2s)-3-amino-2-fluoropropyl]-1-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]urea Chemical compound NC[C@H](F)CN(C(N)=O)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 PRXTZIHOAREPRY-UNMCSNQZSA-N 0.000 claims 1
• ICZADDXNOBXENO-XXBNENTESA-N 1-[(3r)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-hydroxyurea Chemical compound FC[C@H](N)CCN(C(=O)NO)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 ICZADDXNOBXENO-XXBNENTESA-N 0.000 claims 1
• RVDLTNPIDXTVSV-YKSBVNFPSA-N 1-[(3r)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-methylurea Chemical compound FC[C@H](N)CCN(C(=O)NC)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 RVDLTNPIDXTVSV-YKSBVNFPSA-N 0.000 claims 1
• YDWMSPNAYUQWDL-NOZRDPDXSA-N 1-[(3r)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(3-fluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3,3-dimethylurea Chemical compound FC[C@H](N)CCN(C(=O)N(C)C)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC=C1 YDWMSPNAYUQWDL-NOZRDPDXSA-N 0.000 claims 1
• ISYDGWFXLQGWHK-NOZRDPDXSA-N 1-[(3r)-3-amino-4-fluorobutyl]-1-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]-3,3-dimethylurea Chemical compound FC[C@H](N)CCN(C(=O)N(C)C)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 ISYDGWFXLQGWHK-NOZRDPDXSA-N 0.000 claims 1
• SODXCEGXQFQUOV-VWNXMTODSA-N 1-[(3r)-3-amino-4-fluorobutyl]-1-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]-3-methylurea Chemical compound FC[C@H](N)CCN(C(=O)NC)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 SODXCEGXQFQUOV-VWNXMTODSA-N 0.000 claims 1
• HULGNGGZTCIFCP-GGAORHGYSA-N 1-[(3r)-3-amino-4-fluorobutyl]-1-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]urea Chemical compound FC[C@H](N)CCN(C(N)=O)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 HULGNGGZTCIFCP-GGAORHGYSA-N 0.000 claims 1
• ARNPZUZJXXSXHS-OFVILXPXSA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3,3-dimethylurea Chemical compound FC[C@@H](N)CCN(C(=O)N(C)C)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 ARNPZUZJXXSXHS-OFVILXPXSA-N 0.000 claims 1
• XBXBMOXGMVMREX-FIPFOOKPSA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-(3,5-dimethyl-1,2-oxazol-4-yl)urea Chemical compound CC1=NOC(C)=C1NC(=O)N(CC[C@H](N)CF)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 XBXBMOXGMVMREX-FIPFOOKPSA-N 0.000 claims 1
• WDRZFBOGTOAOGD-HOFKKMOUSA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-(cyclopropylmethyl)urea Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)NCC1CC1 WDRZFBOGTOAOGD-HOFKKMOUSA-N 0.000 claims 1
• WDMPIFHQSVFBMG-FIPFOOKPSA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-(oxan-4-yl)urea Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)NC1CCOCC1 WDMPIFHQSVFBMG-FIPFOOKPSA-N 0.000 claims 1
• HLIDBIXNAMAOGF-LVXARBLLSA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-cyclopropylurea Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)NC1CC1 HLIDBIXNAMAOGF-LVXARBLLSA-N 0.000 claims 1
• ICZADDXNOBXENO-CVDCTZTESA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-hydroxyurea Chemical compound FC[C@@H](N)CCN(C(=O)NO)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 ICZADDXNOBXENO-CVDCTZTESA-N 0.000 claims 1
• RVDLTNPIDXTVSV-RDPSFJRHSA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-methylurea Chemical compound FC[C@@H](N)CCN(C(=O)NC)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 RVDLTNPIDXTVSV-RDPSFJRHSA-N 0.000 claims 1
• QASIFHDHOVFUCD-NVQXNPDNSA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-propan-2-ylurea Chemical compound FC[C@@H](N)CCN(C(=O)NC(C)C)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 QASIFHDHOVFUCD-NVQXNPDNSA-N 0.000 claims 1
• YDWMSPNAYUQWDL-ZCYQVOJMSA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[1-benzyl-4-(3-fluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3,3-dimethylurea Chemical compound FC[C@@H](N)CCN(C(=O)N(C)C)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC=C1 YDWMSPNAYUQWDL-ZCYQVOJMSA-N 0.000 claims 1
• ISYDGWFXLQGWHK-ZCYQVOJMSA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]-3,3-dimethylurea Chemical compound FC[C@@H](N)CCN(C(=O)N(C)C)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 ISYDGWFXLQGWHK-ZCYQVOJMSA-N 0.000 claims 1
• SODXCEGXQFQUOV-UPVQGACJSA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]-3-methylurea Chemical compound FC[C@@H](N)CCN(C(=O)NC)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 SODXCEGXQFQUOV-UPVQGACJSA-N 0.000 claims 1
• HULGNGGZTCIFCP-GMAHTHKFSA-N 1-[(3s)-3-amino-4-fluorobutyl]-1-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]urea Chemical compound FC[C@@H](N)CCN(C(N)=O)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 HULGNGGZTCIFCP-GMAHTHKFSA-N 0.000 claims 1
• XYHAEWMSKZBRHX-ZCYQVOJMSA-N 1-[(3s)-3-amino-4-hydroxybutyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3,3-dimethylurea Chemical compound OC[C@@H](N)CCN(C(=O)N(C)C)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 XYHAEWMSKZBRHX-ZCYQVOJMSA-N 0.000 claims 1
• LSQPFPCGALKJSF-AHWVRZQESA-N 1-[(3s)-3-amino-4-hydroxybutyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(2-hydroxyethyl)-3-methylurea Chemical compound OCCN(C)C(=O)N(CC[C@H](N)CO)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 LSQPFPCGALKJSF-AHWVRZQESA-N 0.000 claims 1
• ZBFRHQYCYDCAJQ-AHWVRZQESA-N 1-[(3s)-3-amino-4-hydroxybutyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(2-methoxyethyl)urea Chemical compound COCCNC(=O)N(CC[C@H](N)CO)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 ZBFRHQYCYDCAJQ-AHWVRZQESA-N 0.000 claims 1
• XCFUYPMVSCFLPK-OUTSHDOLSA-N 1-[(3s)-3-amino-4-hydroxybutyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(3,4-difluorophenyl)urea Chemical compound OC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1=CC=C(F)C(F)=C1 XCFUYPMVSCFLPK-OUTSHDOLSA-N 0.000 claims 1
• MQSXYIQNWCKKRG-FIBWVYCGSA-N 1-[(3s)-3-amino-4-hydroxybutyl]-1-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-3-(4-cyanophenyl)urea Chemical compound OC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)NC1=CC=C(C#N)C=C1 MQSXYIQNWCKKRG-FIBWVYCGSA-N 0.000 claims 1
• PAYFEVPWKCEPQP-OFVILXPXSA-N 1-[(3s)-3-amino-4-methoxybutyl]-1-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-3-methylurea Chemical compound COC[C@@H](N)CCN(C(=O)NC)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 PAYFEVPWKCEPQP-OFVILXPXSA-N 0.000 claims 1
• MXKVRTIDFMDMOQ-ZCYQVOJMSA-N 1-[(3s)-3-amino-4-methoxybutyl]-1-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]-3-methylurea Chemical compound COC[C@@H](N)CCN(C(=O)NC)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 MXKVRTIDFMDMOQ-ZCYQVOJMSA-N 0.000 claims 1
• 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
• KETQYEGNQCNKPR-UHFFFAOYSA-N 4-methylsulfonylpiperidine-1-carboxylic acid Chemical compound CS(=O)(=O)C1CCN(C(O)=O)CC1 KETQYEGNQCNKPR-UHFFFAOYSA-N 0.000 claims 1
• 125000006295 amino methylene group Chemical group [H]N(*)C([H])([H])* 0.000 claims 1
• 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 1
• 150000003857 carboxamides Chemical class 0.000 claims 1
• WINCHWWCGNAVHL-QCDSWUKFSA-N ethyl 4-[[[(3s)-3-amino-4-fluorobutyl]-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]carbamoyl]amino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCC1NC(=O)N(CC[C@H](N)CF)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 WINCHWWCGNAVHL-QCDSWUKFSA-N 0.000 claims 1
• NWNCRBMVVJLTOK-HMCKCBAOSA-N methyl (2s)-1-[(3-amino-4-fluorobutyl)-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]carbamoyl]pyrrolidine-2-carboxylate Chemical compound COC(=O)[C@@H]1CCCN1C(=O)N(CCC(N)CF)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 NWNCRBMVVJLTOK-HMCKCBAOSA-N 0.000 claims 1
• 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims 1
• JTJUYXKTSKNXKJ-GPNIZQGCSA-N n-(3-amino-2-fluoropropyl)-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-4-methylpiperazine-1-carboxamide Chemical compound C1CN(C)CCN1C(=O)N(CC(F)CN)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 JTJUYXKTSKNXKJ-GPNIZQGCSA-N 0.000 claims 1
• QRERBASGVUXDOO-VQSVVBPOSA-N n-(3-amino-2-fluoropropyl)-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-4-piperidin-1-ylpiperidine-1-carboxamide Chemical compound NCC(F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N(CC1)CCC1N1CCCCC1 QRERBASGVUXDOO-VQSVVBPOSA-N 0.000 claims 1
• VILHOXBNPNNASJ-YTTGMZPUSA-N n-(3-aminopropyl)-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-4-piperidin-1-ylpiperidine-1-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N(CC1)CCC1N1CCCCC1 VILHOXBNPNNASJ-YTTGMZPUSA-N 0.000 claims 1
• QPTNHNBOUKXSTB-SANMLTNESA-N n-(3-aminopropyl)-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-1,1-dioxo-1,4-thiazinane-4-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCS(=O)(=O)CC1 QPTNHNBOUKXSTB-SANMLTNESA-N 0.000 claims 1
• CVOLJCPRUKJITP-VWLOTQADSA-N n-(3-aminopropyl)-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-1,2-oxazolidine-2-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCCO1 CVOLJCPRUKJITP-VWLOTQADSA-N 0.000 claims 1
• GVXAWCWMNXIFDO-SANMLTNESA-N n-(3-aminopropyl)-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-1-oxo-1,4-thiazinane-4-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCS(=O)CC1 GVXAWCWMNXIFDO-SANMLTNESA-N 0.000 claims 1
• YFFQZXGYERELSU-MHZLTWQESA-N n-(3-aminopropyl)-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-4-methylsulfonylpiperazine-1-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCN(S(C)(=O)=O)CC1 YFFQZXGYERELSU-MHZLTWQESA-N 0.000 claims 1
• GRFZGLXGUSODIR-NDEPHWFRSA-N n-(3-aminopropyl)-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-4-methylsulfonylpiperidine-1-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCC(S(C)(=O)=O)CC1 GRFZGLXGUSODIR-NDEPHWFRSA-N 0.000 claims 1
• GWGQEAFRHMIBQZ-SANMLTNESA-N n-(3-aminopropyl)-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCOCC1 GWGQEAFRHMIBQZ-SANMLTNESA-N 0.000 claims 1
• HAYOLSBUPDAAFR-SANMLTNESA-N n-(3-aminopropyl)-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]pyrrolidine-1-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCCC1 HAYOLSBUPDAAFR-SANMLTNESA-N 0.000 claims 1
• KFBDRWSKOKDLGA-SANMLTNESA-N n-(3-aminopropyl)-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]thiomorpholine-4-carboxamide Chemical compound NCCCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCSCC1 KFBDRWSKOKDLGA-SANMLTNESA-N 0.000 claims 1
• PFJJWJVGSFTJTH-MYZAEBQFSA-N n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-n-[[(2s,3s)-2-(hydroxymethyl)pyrrolidin-3-yl]methyl]-4-piperidin-1-ylpiperidine-1-carboxamide Chemical compound C1CC(N2CCCCC2)CCN1C(=O)N([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C[C@@H]1CCN[C@@H]1CO PFJJWJVGSFTJTH-MYZAEBQFSA-N 0.000 claims 1
• OQQGSNZUZZLOEB-SQHAQQRYSA-N n-[(2r)-3-amino-2-fluoropropyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-4-hydroxypiperidine-1-carboxamide Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N1CCC(O)CC1 OQQGSNZUZZLOEB-SQHAQQRYSA-N 0.000 claims 1
• JTJUYXKTSKNXKJ-VPUSJEBWSA-N n-[(2r)-3-amino-2-fluoropropyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-4-methylpiperazine-1-carboxamide Chemical compound C1CN(C)CCN1C(=O)N(C[C@H](F)CN)[C@H](C(C)(C)C)C1=NC(C=2C=CC=CC=2)=CN1CC1=CC=CC=C1 JTJUYXKTSKNXKJ-VPUSJEBWSA-N 0.000 claims 1
• JUIUSIXTGGMBMU-MVSFAKPFSA-N n-[(2r)-3-amino-2-fluoropropyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-4-morpholin-4-ylpiperidine-1-carboxamide Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N(CC1)CCC1N1CCOCC1 JUIUSIXTGGMBMU-MVSFAKPFSA-N 0.000 claims 1
• QRERBASGVUXDOO-PPTMTGTBSA-N n-[(2r)-3-amino-2-fluoropropyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-4-piperidin-1-ylpiperidine-1-carboxamide Chemical compound NC[C@@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N(CC1)CCC1N1CCCCC1 QRERBASGVUXDOO-PPTMTGTBSA-N 0.000 claims 1
• OQQGSNZUZZLOEB-IGKIAQTJSA-N n-[(2s)-3-amino-2-fluoropropyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-4-hydroxypiperidine-1-carboxamide Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N1CCC(O)CC1 OQQGSNZUZZLOEB-IGKIAQTJSA-N 0.000 claims 1
• JUIUSIXTGGMBMU-IZEXYCQBSA-N n-[(2s)-3-amino-2-fluoropropyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-4-morpholin-4-ylpiperidine-1-carboxamide Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N(CC1)CCC1N1CCOCC1 JUIUSIXTGGMBMU-IZEXYCQBSA-N 0.000 claims 1
• IXAWNMFOGASVRI-NVQXNPDNSA-N n-[(2s)-3-amino-2-fluoropropyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-1,1-dioxo-1,4-thiazinane-4-carboxamide Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCS(=O)(=O)CC1 IXAWNMFOGASVRI-NVQXNPDNSA-N 0.000 claims 1
• NLTOYYKBJIXYEK-OFVILXPXSA-N n-[(2s)-3-amino-2-fluoropropyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-1,2-oxazolidine-2-carboxamide Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCCO1 NLTOYYKBJIXYEK-OFVILXPXSA-N 0.000 claims 1
• VYAFZIUVNPMZSB-HOFKKMOUSA-N n-[(2s)-3-amino-2-fluoropropyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-4-methylsulfonylpiperazine-1-carboxamide Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCN(S(C)(=O)=O)CC1 VYAFZIUVNPMZSB-HOFKKMOUSA-N 0.000 claims 1
• DQWLSBBNKJZCDQ-NVQXNPDNSA-N n-[(2s)-3-amino-2-fluoropropyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCOCC1 DQWLSBBNKJZCDQ-NVQXNPDNSA-N 0.000 claims 1
• UPKBEJMJQXWBFS-NVQXNPDNSA-N n-[(2s)-3-amino-2-fluoropropyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]pyrrolidine-1-carboxamide Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCCC1 UPKBEJMJQXWBFS-NVQXNPDNSA-N 0.000 claims 1
• KHNVWRYBXXRUJI-AHWVRZQESA-N n-[(2s)-3-amino-2-fluoropropyl]-n-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]-1,1-dioxo-1,4-thiazinane-4-carboxamide Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=C(F)C=CC=1)C(=O)N1CCS(=O)(=O)CC1 KHNVWRYBXXRUJI-AHWVRZQESA-N 0.000 claims 1
• SFJILJWDQNFIKK-AHWVRZQESA-N n-[(2s)-3-amino-2-fluoropropyl]-n-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=C(F)C=CC=1)C(=O)N1CCOCC1 SFJILJWDQNFIKK-AHWVRZQESA-N 0.000 claims 1
• FKOSHJJEAIXRGN-AHWVRZQESA-N n-[(2s)-3-amino-2-fluoropropyl]-n-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]pyrrolidine-1-carboxamide Chemical compound NC[C@H](F)CN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=C(F)C=CC=1)C(=O)N1CCCC1 FKOSHJJEAIXRGN-AHWVRZQESA-N 0.000 claims 1
• CQINGPDJTKEROC-AMGIVPHBSA-N n-[(3r)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,3,5-trifluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound FC[C@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=C(F)C=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCOCC1 CQINGPDJTKEROC-AMGIVPHBSA-N 0.000 claims 1
• UGPPAJCGNZDYCV-KCWPFWIISA-N n-[(3r)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]pyrrolidine-1-carboxamide Chemical compound FC[C@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCCC1 UGPPAJCGNZDYCV-KCWPFWIISA-N 0.000 claims 1
• MPSRONJGXFCZDM-VPUSJEBWSA-N n-[(3r)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(3-fluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-1,1-dioxo-1,4-thiazinane-4-carboxamide Chemical compound FC[C@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=CC=CC=1)C(=O)N1CCS(=O)(=O)CC1 MPSRONJGXFCZDM-VPUSJEBWSA-N 0.000 claims 1
• ZUMQAZJUYQFKAA-VPUSJEBWSA-N n-[(3r)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(3-fluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound FC[C@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=CC=CC=1)C(=O)N1CCOCC1 ZUMQAZJUYQFKAA-VPUSJEBWSA-N 0.000 claims 1
• ZSDKBRVHKNQHLR-IAPPQJPRSA-N n-[(3r)-3-amino-4-fluorobutyl]-n-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]-4-methylpiperazine-1-carboxamide Chemical compound C1CN(C)CCN1C(=O)N(CC[C@@H](N)CF)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 ZSDKBRVHKNQHLR-IAPPQJPRSA-N 0.000 claims 1
• WGGUJFNTZOAVAJ-VPUSJEBWSA-N n-[(3r)-3-amino-4-fluorobutyl]-n-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound FC[C@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=C(F)C=CC=1)C(=O)N1CCOCC1 WGGUJFNTZOAVAJ-VPUSJEBWSA-N 0.000 claims 1
• ORWSJXIZWIEYTP-VPUSJEBWSA-N n-[(3r)-3-amino-4-fluorobutyl]-n-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]pyrrolidine-1-carboxamide Chemical compound FC[C@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=C(F)C=CC=1)C(=O)N1CCCC1 ORWSJXIZWIEYTP-VPUSJEBWSA-N 0.000 claims 1
• XPZRKBFWVHUFKF-ZBLYBZFDSA-N n-[(3r)-3-aminobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound C1([C@H](N(CC[C@H](N)C)C(=O)N2CCOCC2)C(C)(C)C)=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 XPZRKBFWVHUFKF-ZBLYBZFDSA-N 0.000 claims 1
• YNBHMBJAXXOLGT-IDISGSTGSA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-[(3-hydroxyphenyl)methyl]-4-(2,3,5-trifluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=C(F)C=C(F)C=1)F)CC=1C=C(O)C=CC=1)C(=O)N1CCOCC1 YNBHMBJAXXOLGT-IDISGSTGSA-N 0.000 claims 1
• CQINGPDJTKEROC-CUNXSJBXSA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,3,5-trifluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=C(F)C=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCOCC1 CQINGPDJTKEROC-CUNXSJBXSA-N 0.000 claims 1
• CLSYLZYXGXPAGF-HOFKKMOUSA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-1,1-dioxo-1,4-thiazinane-4-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCS(=O)(=O)CC1 CLSYLZYXGXPAGF-HOFKKMOUSA-N 0.000 claims 1
• CYIDPIBKEYZKSE-NVQXNPDNSA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-1,2-oxazolidine-2-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCCO1 CYIDPIBKEYZKSE-NVQXNPDNSA-N 0.000 claims 1
• WNSSQOLIMSBSBS-CUBQBAPOSA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-4-methylsulfonylpiperazine-1-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCN(S(C)(=O)=O)CC1 WNSSQOLIMSBSBS-CUBQBAPOSA-N 0.000 claims 1
• RRNQZMLTVYYFRD-YZNIXAGQSA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-4-propan-2-ylpiperazine-1-carboxamide Chemical compound C1CN(C(C)C)CCN1C(=O)N(CC[C@H](N)CF)[C@H](C(C)(C)C)C1=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 RRNQZMLTVYYFRD-YZNIXAGQSA-N 0.000 claims 1
• NFLXLTRYDSZZKZ-HOFKKMOUSA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCOCC1 NFLXLTRYDSZZKZ-HOFKKMOUSA-N 0.000 claims 1
• UGPPAJCGNZDYCV-HOFKKMOUSA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]pyrrolidine-1-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCCC1 UGPPAJCGNZDYCV-HOFKKMOUSA-N 0.000 claims 1
• MPSRONJGXFCZDM-BDYUSTAISA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(3-fluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-1,1-dioxo-1,4-thiazinane-4-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=CC=CC=1)C(=O)N1CCS(=O)(=O)CC1 MPSRONJGXFCZDM-BDYUSTAISA-N 0.000 claims 1
• USGXCPOIYOWGCN-WNJJXGMVSA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(3-fluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]-4-methylsulfonylpiperidine-1-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=CC=CC=1)C(=O)N1CCC(S(C)(=O)=O)CC1 USGXCPOIYOWGCN-WNJJXGMVSA-N 0.000 claims 1
• ZUMQAZJUYQFKAA-BDYUSTAISA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[1-benzyl-4-(3-fluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=CC=CC=1)C(=O)N1CCOCC1 ZUMQAZJUYQFKAA-BDYUSTAISA-N 0.000 claims 1
• ZSDKBRVHKNQHLR-XCZPVHLTSA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]-4-methylpiperazine-1-carboxamide Chemical compound C1CN(C)CCN1C(=O)N(CC[C@H](N)CF)[C@H](C(C)(C)C)C1=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 ZSDKBRVHKNQHLR-XCZPVHLTSA-N 0.000 claims 1
• WGGUJFNTZOAVAJ-BDYUSTAISA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=C(F)C=CC=1)C(=O)N1CCOCC1 WGGUJFNTZOAVAJ-BDYUSTAISA-N 0.000 claims 1
• ORWSJXIZWIEYTP-BDYUSTAISA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]pyrrolidine-1-carboxamide Chemical compound FC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=C(F)C=CC=1)CC=1C=C(F)C=CC=1)C(=O)N1CCCC1 ORWSJXIZWIEYTP-BDYUSTAISA-N 0.000 claims 1
• NFLXLTRYDSZZKZ-WNCULLNHSA-N n-[(3s)-3-amino-4-fluorobutyl]-n-[(1s)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound FC[C@@H](N)CCN([C@@H](C(C)(C)C)C=1N(C=C(N=1)C=1C(=CC=C(F)C=1)F)CC=1C=CC=CC=1)C(=O)N1CCOCC1 NFLXLTRYDSZZKZ-WNCULLNHSA-N 0.000 claims 1
• YMJTXMKVRWUIAY-DITALETJSA-N n-[(3s)-3-amino-4-hydroxybutyl]-n-[(1r)-1-(1-benzyl-4-phenylimidazol-2-yl)-2,2-dimethylpropyl]-4-piperidin-1-ylpiperidine-1-carboxamide Chemical compound OC[C@@H](N)CCN([C@H](C(C)(C)C)C=1N(C=C(N=1)C=1C=CC=CC=1)CC=1C=CC=CC=1)C(=O)N(CC1)CCC1N1CCCCC1 YMJTXMKVRWUIAY-DITALETJSA-N 0.000 claims 1
• FPDGYYICGLSLTH-CUBQBAPOSA-N n-[(3s)-3-amino-4-methoxybutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound C1([C@H](N(CC[C@H](N)COC)C(=O)N2CCOCC2)C(C)(C)C)=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 FPDGYYICGLSLTH-CUBQBAPOSA-N 0.000 claims 1
• HQNUWACNDGZSCL-XCZPVHLTSA-N n-[(3s)-3-amino-4-methoxybutyl]-n-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound C1([C@H](N(CC[C@H](N)COC)C(=O)N2CCOCC2)C(C)(C)C)=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 HQNUWACNDGZSCL-XCZPVHLTSA-N 0.000 claims 1
• SYONFYSNXXHYIA-XCZPVHLTSA-N n-[(3s)-3-amino-4-methoxybutyl]-n-[(1r)-1-[4-(3-fluorophenyl)-1-[(3-fluorophenyl)methyl]imidazol-2-yl]-2,2-dimethylpropyl]pyrrolidine-1-carboxamide Chemical compound C1([C@H](N(CC[C@H](N)COC)C(=O)N2CCCC2)C(C)(C)C)=NC(C=2C=C(F)C=CC=2)=CN1CC1=CC=CC(F)=C1 SYONFYSNXXHYIA-XCZPVHLTSA-N 0.000 claims 1
• XPZRKBFWVHUFKF-IDISGSTGSA-N n-[(3s)-3-aminobutyl]-n-[(1r)-1-[1-benzyl-4-(2,5-difluorophenyl)imidazol-2-yl]-2,2-dimethylpropyl]morpholine-4-carboxamide Chemical compound C1([C@H](N(CC[C@@H](N)C)C(=O)N2CCOCC2)C(C)(C)C)=NC(C=2C(=CC=C(F)C=2)F)=CN1CC1=CC=CC=C1 XPZRKBFWVHUFKF-IDISGSTGSA-N 0.000 claims 1
• JSPCTNUQYWIIOT-UHFFFAOYSA-N piperidine-1-carboxamide Chemical compound NC(=O)N1CCCCC1 JSPCTNUQYWIIOT-UHFFFAOYSA-N 0.000 claims 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-M prolinate Chemical compound [O-]C(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-M 0.000 claims 1
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 113
• 239000000203 mixture Substances 0.000 description 107
• 238000006243 chemical reaction Methods 0.000 description 68
• 239000000243 solution Substances 0.000 description 61
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 53
• 235000019439 ethyl acetate Nutrition 0.000 description 52
• 239000000047 product Substances 0.000 description 48
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 44
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 42
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 40
• 239000002904 solvent Substances 0.000 description 35
• 210000004027 cell Anatomy 0.000 description 34
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 33
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 31
• 230000015572 biosynthetic process Effects 0.000 description 30
• 206010028980 Neoplasm Diseases 0.000 description 29
• 239000004480 active ingredient Substances 0.000 description 29
• 239000011541 reaction mixture Substances 0.000 description 29
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 27
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 25
• 238000002360 preparation method Methods 0.000 description 25
• 238000009472 formulation Methods 0.000 description 24
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 24
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 23
• 239000012267 brine Substances 0.000 description 23
• 239000011734 sodium Substances 0.000 description 23
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 21
• 201000011510 cancer Diseases 0.000 description 21
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 20
• 230000002829 reductive effect Effects 0.000 description 20
• 238000004128 high performance liquid chromatography Methods 0.000 description 19
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
• 125000004435 hydrogen atom Chemical class [H]* 0.000 description 18
• 239000003921 oil Substances 0.000 description 18
• 235000019198 oils Nutrition 0.000 description 18
• 239000007787 solid Substances 0.000 description 18
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 17
• 125000001424 substituent group Chemical group 0.000 description 17
• 238000005481 NMR spectroscopy Methods 0.000 description 16
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 16
• 238000003756 stirring Methods 0.000 description 16
• 229920006395 saturated elastomer Polymers 0.000 description 15
• 238000003786 synthesis reaction Methods 0.000 description 14
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
• 239000002253 acid Substances 0.000 description 13
• 239000003814 drug Substances 0.000 description 13
• 239000004615 ingredient Substances 0.000 description 13
• 239000012044 organic layer Substances 0.000 description 13
• 239000012074 organic phase Substances 0.000 description 13
• 230000008569 process Effects 0.000 description 13
• 238000000746 purification Methods 0.000 description 13
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 12
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 12
• 125000004104 aryloxy group Chemical group 0.000 description 12
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
• 239000000546 pharmaceutical excipient Substances 0.000 description 12
• 229940079593 drug Drugs 0.000 description 11
• 239000003826 tablet Substances 0.000 description 11
• 238000004809 thin layer chromatography Methods 0.000 description 11
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 10
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
• 229920002472 Starch Polymers 0.000 description 10
• 239000007864 aqueous solution Substances 0.000 description 10
• 230000004071 biological effect Effects 0.000 description 10
• 239000008194 pharmaceutical composition Substances 0.000 description 10
• 239000000741 silica gel Substances 0.000 description 10
• 229910002027 silica gel Inorganic materials 0.000 description 10
• 229910052938 sodium sulfate Inorganic materials 0.000 description 10
• 235000011152 sodium sulphate Nutrition 0.000 description 10
• 239000008107 starch Substances 0.000 description 10
• 235000019698 starch Nutrition 0.000 description 10
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
• 102000029749 Microtubule Human genes 0.000 description 9
• 108091022875 Microtubule Proteins 0.000 description 9
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
• 210000004688 microtubule Anatomy 0.000 description 9
• KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 9
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 8
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
• 238000003556 assay Methods 0.000 description 8
• 239000012043 crude product Substances 0.000 description 8
• 150000002148 esters Chemical class 0.000 description 8
• 235000019359 magnesium stearate Nutrition 0.000 description 8
• 239000012071 phase Substances 0.000 description 8
• 229940002612 prodrug Drugs 0.000 description 8
• 239000000651 prodrug Substances 0.000 description 8
• 108090000623 proteins and genes Proteins 0.000 description 8
• 241000124008 Mammalia Species 0.000 description 7
• 150000001412 amines Chemical class 0.000 description 7
• 239000002246 antineoplastic agent Substances 0.000 description 7
• 239000003795 chemical substances by application Substances 0.000 description 7
• 208000035475 disorder Diseases 0.000 description 7
• 239000002552 dosage form Substances 0.000 description 7
• 238000001704 evaporation Methods 0.000 description 7
• 230000008020 evaporation Effects 0.000 description 7
• 238000001914 filtration Methods 0.000 description 7
• 238000001727 in vivo Methods 0.000 description 7
• 239000000543 intermediate Substances 0.000 description 7
• 239000007788 liquid Substances 0.000 description 7
• 239000000463 material Substances 0.000 description 7
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 7
• 102000004169 proteins and genes Human genes 0.000 description 7
• 238000006467 substitution reaction Methods 0.000 description 7
• 230000001225 therapeutic effect Effects 0.000 description 7
• SEULWJSKCVACTH-UHFFFAOYSA-N 1-phenylimidazole Chemical compound C1=NC=CN1C1=CC=CC=C1 SEULWJSKCVACTH-UHFFFAOYSA-N 0.000 description 6
• ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 6
• 101001008953 Homo sapiens Kinesin-like protein KIF11 Proteins 0.000 description 6
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 6
• 150000007513 acids Chemical class 0.000 description 6
• 125000002252 acyl group Chemical group 0.000 description 6
• 125000004423 acyloxy group Chemical group 0.000 description 6
• 239000002585 base Substances 0.000 description 6
• SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 6
• 230000037396 body weight Effects 0.000 description 6
• 239000002775 capsule Substances 0.000 description 6
• 230000000694 effects Effects 0.000 description 6
• 229960002989 glutamic acid Drugs 0.000 description 6
• 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 6
• 229910052698 phosphorus Inorganic materials 0.000 description 6
• 230000002441 reversible effect Effects 0.000 description 6
• 239000000725 suspension Substances 0.000 description 6
• 108010063296 Kinesin Proteins 0.000 description 5
• 102000010638 Kinesin Human genes 0.000 description 5
• 102100027629 Kinesin-like protein KIF11 Human genes 0.000 description 5
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 5
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
• 150000001299 aldehydes Chemical group 0.000 description 5
• 150000001721 carbon Chemical group 0.000 description 5
• 238000004587 chromatography analysis Methods 0.000 description 5
• 238000010511 deprotection reaction Methods 0.000 description 5
• 239000000706 filtrate Substances 0.000 description 5
• 238000003818 flash chromatography Methods 0.000 description 5
• 239000007903 gelatin capsule Substances 0.000 description 5
• 230000012010 growth Effects 0.000 description 5
• 229910052736 halogen Inorganic materials 0.000 description 5
• 150000002367 halogens Chemical class 0.000 description 5
• WHHNAMFLUXPVNV-JEDNCBNOSA-N methyl (2s)-2-aminopent-4-enoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CC=C WHHNAMFLUXPVNV-JEDNCBNOSA-N 0.000 description 5
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 5
• 239000008108 microcrystalline cellulose Substances 0.000 description 5
• 229940016286 microcrystalline cellulose Drugs 0.000 description 5
• 239000012299 nitrogen atmosphere Substances 0.000 description 5
• 230000003287 optical effect Effects 0.000 description 5
• 239000000843 powder Substances 0.000 description 5
• 239000007858 starting material Substances 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 238000012360 testing method Methods 0.000 description 5
• WNNNWFKQCKFSDK-BYPYZUCNSA-N (2s)-2-aminopent-4-enoic acid Chemical compound OC(=O)[C@@H](N)CC=C WNNNWFKQCKFSDK-BYPYZUCNSA-N 0.000 description 4
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
• 206010009944 Colon cancer Diseases 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 241001465754 Metazoa Species 0.000 description 4
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
• 0 O=CC1C*CC1 Chemical compound O=CC1C*CC1 0.000 description 4
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
• 125000004414 alkyl thio group Chemical group 0.000 description 4
• SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 4
• 150000001414 amino alcohols Chemical class 0.000 description 4
• 238000010171 animal model Methods 0.000 description 4
• 229940041181 antineoplastic drug Drugs 0.000 description 4
• 125000005110 aryl thio group Chemical group 0.000 description 4
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
• 238000004113 cell culture Methods 0.000 description 4
• 239000003153 chemical reaction reagent Substances 0.000 description 4
• 208000029742 colonic neoplasm Diseases 0.000 description 4
• 238000007796 conventional method Methods 0.000 description 4
• 125000004122 cyclic group Chemical group 0.000 description 4
• 125000005366 cycloalkylthio group Chemical group 0.000 description 4
• 201000010099 disease Diseases 0.000 description 4
• 239000003937 drug carrier Substances 0.000 description 4
• 238000000605 extraction Methods 0.000 description 4
• 239000012065 filter cake Substances 0.000 description 4
• 125000005553 heteroaryloxy group Chemical group 0.000 description 4
• 125000005368 heteroarylthio group Chemical group 0.000 description 4
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
• 235000019341 magnesium sulphate Nutrition 0.000 description 4
• 230000000394 mitotic effect Effects 0.000 description 4
• FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 4
• 229910052760 oxygen Inorganic materials 0.000 description 4
• 239000001301 oxygen Substances 0.000 description 4
• 239000002245 particle Substances 0.000 description 4
• 239000006187 pill Substances 0.000 description 4
• 125000006239 protecting group Chemical group 0.000 description 4
• 229930002330 retinoic acid Natural products 0.000 description 4
• 229910052708 sodium Inorganic materials 0.000 description 4
• 238000010186 staining Methods 0.000 description 4
• 229910052717 sulfur Chemical group 0.000 description 4
• 239000011593 sulfur Chemical group 0.000 description 4
• DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 4
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 3
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
• ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 3
• 229920001817 Agar Polymers 0.000 description 3
• 206010006187 Breast cancer Diseases 0.000 description 3
• 208000026310 Breast neoplasm Diseases 0.000 description 3
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 3
• CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 3
• 201000009030 Carcinoma Diseases 0.000 description 3
• 238000012369 In process control Methods 0.000 description 3
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
• SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
• 239000012980 RPMI-1640 medium Substances 0.000 description 3
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
• UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• 235000011054 acetic acid Nutrition 0.000 description 3
• 239000008272 agar Substances 0.000 description 3
• 229940024606 amino acid Drugs 0.000 description 3
• 150000001413 amino acids Chemical class 0.000 description 3
• XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 3
• AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 3
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
• 230000008499 blood brain barrier function Effects 0.000 description 3
• 210000001218 blood-brain barrier Anatomy 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 239000003054 catalyst Substances 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 238000004440 column chromatography Methods 0.000 description 3
• 239000013058 crude material Substances 0.000 description 3
• 238000012377 drug delivery Methods 0.000 description 3
• 239000012055 enteric layer Substances 0.000 description 3
• 239000000796 flavoring agent Substances 0.000 description 3
• 235000019634 flavors Nutrition 0.000 description 3
• 239000006260 foam Substances 0.000 description 3
• 125000000524 functional group Chemical group 0.000 description 3
• 125000005844 heterocyclyloxy group Chemical group 0.000 description 3
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
• 238000000338 in vitro Methods 0.000 description 3
• 238000010965 in-process control Methods 0.000 description 3
• 238000011534 incubation Methods 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 239000002609 medium Substances 0.000 description 3
• 229910052763 palladium Inorganic materials 0.000 description 3
• LUYQYZLEHLTPBH-UHFFFAOYSA-N perfluorobutanesulfonyl fluoride Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)S(F)(=O)=O LUYQYZLEHLTPBH-UHFFFAOYSA-N 0.000 description 3
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 3
• 238000002953 preparative HPLC Methods 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 230000002062 proliferating effect Effects 0.000 description 3
• 239000000376 reactant Substances 0.000 description 3
• 238000000926 separation method Methods 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• 239000000377 silicon dioxide Substances 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 239000000829 suppository Substances 0.000 description 3
• 239000000454 talc Substances 0.000 description 3
• 229910052623 talc Inorganic materials 0.000 description 3
• 235000012222 talc Nutrition 0.000 description 3
• 230000000699 topical effect Effects 0.000 description 3
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
• XAEQIUFFBRKYDS-HNNXBMFYSA-N (2s)-2-(1,3-dioxoisoindol-2-yl)-4-oxo-4-phenylmethoxybutanoic acid Chemical compound C([C@@H](C(=O)O)N1C(C2=CC=CC=C2C1=O)=O)C(=O)OCC1=CC=CC=C1 XAEQIUFFBRKYDS-HNNXBMFYSA-N 0.000 description 2
• XNUXSAGMXTXYOS-QMMMGPOBSA-N (3s)-3-(1,3-dioxoisoindol-2-yl)-4-fluorobutanal Chemical compound C1=CC=C2C(=O)N([C@@H](CC=O)CF)C(=O)C2=C1 XNUXSAGMXTXYOS-QMMMGPOBSA-N 0.000 description 2
• IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
• LOBCDGHHHHGHFA-LBPRGKRZSA-N (S)-monastrol Chemical compound CCOC(=O)C1=C(C)NC(=S)N[C@H]1C1=CC=CC(O)=C1 LOBCDGHHHHGHFA-LBPRGKRZSA-N 0.000 description 2
• UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
• BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 2
• FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
• WNNNWFKQCKFSDK-UHFFFAOYSA-N 2-Amino-4-pentenoic acid Natural products OC(=O)C(N)CC=C WNNNWFKQCKFSDK-UHFFFAOYSA-N 0.000 description 2
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
• GIJSYLHKJRKNDW-UHFFFAOYSA-N 2-o-(2,5-dioxopyrrolidin-1-yl) 1-o-methyl benzene-1,2-dicarboxylate Chemical compound COC(=O)C1=CC=CC=C1C(=O)ON1C(=O)CCC1=O GIJSYLHKJRKNDW-UHFFFAOYSA-N 0.000 description 2
• NODFMZCEEBQXME-UHFFFAOYSA-N 5-phenyl-1h-imidazol-2-amine Chemical compound N1C(N)=NC(C=2C=CC=CC=2)=C1 NODFMZCEEBQXME-UHFFFAOYSA-N 0.000 description 2
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
• USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
• 239000005695 Ammonium acetate Substances 0.000 description 2
• 241000283690 Bos taurus Species 0.000 description 2
• 208000003174 Brain Neoplasms Diseases 0.000 description 2
• CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
• ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
• QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
• 208000008839 Kidney Neoplasms Diseases 0.000 description 2
• 229910010082 LiAlH Inorganic materials 0.000 description 2
• 208000003445 Mouth Neoplasms Diseases 0.000 description 2
• 241000872931 Myoporum sandwicense Species 0.000 description 2
• 150000001204 N-oxides Chemical class 0.000 description 2
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
• PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
• KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
• KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
• SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
• 206010038389 Renal cancer Diseases 0.000 description 2
• 108091013841 Spermatogenesis-associated protein 6 Proteins 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
• 208000024770 Thyroid neoplasm Diseases 0.000 description 2
• 238000002835 absorbance Methods 0.000 description 2
• 238000010521 absorption reaction Methods 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
• 229940072056 alginate Drugs 0.000 description 2
• 235000010443 alginic acid Nutrition 0.000 description 2
• 229920000615 alginic acid Polymers 0.000 description 2
• 125000001931 aliphatic group Chemical group 0.000 description 2
• 229910052783 alkali metal Inorganic materials 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
• 229910021529 ammonia Inorganic materials 0.000 description 2
• 229940043376 ammonium acetate Drugs 0.000 description 2
• 235000019257 ammonium acetate Nutrition 0.000 description 2
• 238000004458 analytical method Methods 0.000 description 2
• 239000012131 assay buffer Substances 0.000 description 2
• 239000005441 aurora Substances 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• RPCRQKRJUORZAJ-AWEZNQCLSA-N benzyl (3s)-3-(1,3-dioxoisoindol-2-yl)-4-hydroxybutanoate Chemical compound C([C@@H](CO)N1C(C2=CC=CC=C2C1=O)=O)C(=O)OCC1=CC=CC=C1 RPCRQKRJUORZAJ-AWEZNQCLSA-N 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• 239000006227 byproduct Substances 0.000 description 2
• TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 2
• 239000012830 cancer therapeutic Substances 0.000 description 2
• 239000001768 carboxy methyl cellulose Substances 0.000 description 2
• 150000001768 cations Chemical class 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 238000001516 cell proliferation assay Methods 0.000 description 2
• 238000012054 celltiter-glo Methods 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229940044683 chemotherapy drug Drugs 0.000 description 2
• 239000012230 colorless oil Substances 0.000 description 2
• 239000002285 corn oil Substances 0.000 description 2
• 235000005687 corn oil Nutrition 0.000 description 2
• 230000003111 delayed effect Effects 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
• 231100000673 dose–response relationship Toxicity 0.000 description 2
• 238000009509 drug development Methods 0.000 description 2
• 125000004185 ester group Chemical group 0.000 description 2
• DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
• 239000002024 ethyl acetate extract Substances 0.000 description 2
• 238000005187 foaming Methods 0.000 description 2
• 125000002541 furyl group Chemical group 0.000 description 2
• 239000007789 gas Substances 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 238000010438 heat treatment Methods 0.000 description 2
• 125000005842 heteroatom Chemical group 0.000 description 2
• 125000000592 heterocycloalkyl group Chemical group 0.000 description 2
• BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
• 125000001183 hydrocarbyl group Chemical group 0.000 description 2
• 239000005457 ice water Substances 0.000 description 2
• 238000011065 in-situ storage Methods 0.000 description 2
• 239000012442 inert solvent Substances 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
• 201000010982 kidney cancer Diseases 0.000 description 2
• 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• 229940057995 liquid paraffin Drugs 0.000 description 2
• 238000004020 luminiscence type Methods 0.000 description 2
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
• 230000036210 malignancy Effects 0.000 description 2
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
• 238000004949 mass spectrometry Methods 0.000 description 2
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
• ANSUDRATXSJBLY-GSVOUGTGSA-N methyl (2r)-2-amino-3-hydroxypropanoate Chemical compound COC(=O)[C@H](N)CO ANSUDRATXSJBLY-GSVOUGTGSA-N 0.000 description 2
• 150000007522 mineralic acids Chemical class 0.000 description 2
• 125000001624 naphthyl group Chemical group 0.000 description 2
• 150000007524 organic acids Chemical class 0.000 description 2
• 239000003960 organic solvent Substances 0.000 description 2
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
• 230000003647 oxidation Effects 0.000 description 2
• 238000007254 oxidation reaction Methods 0.000 description 2
• 201000002528 pancreatic cancer Diseases 0.000 description 2
• 208000008443 pancreatic carcinoma Diseases 0.000 description 2
• 239000012188 paraffin wax Substances 0.000 description 2
• 229940124531 pharmaceutical excipient Drugs 0.000 description 2
• LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 2
• RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
• 239000000049 pigment Substances 0.000 description 2
• 230000036470 plasma concentration Effects 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 2
• 229940074439 potassium sodium tartrate Drugs 0.000 description 2
• 150000003141 primary amines Chemical class 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 125000004076 pyridyl group Chemical group 0.000 description 2
• 238000006268 reductive amination reaction Methods 0.000 description 2
• 238000010992 reflux Methods 0.000 description 2
• 238000004007 reversed phase HPLC Methods 0.000 description 2
• WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
• 239000004299 sodium benzoate Substances 0.000 description 2
• 235000010234 sodium benzoate Nutrition 0.000 description 2
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
• 235000011006 sodium potassium tartrate Nutrition 0.000 description 2
• 239000008247 solid mixture Substances 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 238000000967 suction filtration Methods 0.000 description 2
• 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
• YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 239000006188 syrup Substances 0.000 description 2
• 235000020357 syrup Nutrition 0.000 description 2
• VNOWIHHJPAJYHL-UHFFFAOYSA-N tert-butyl n-(2-methyl-4-oxobutan-2-yl)carbamate Chemical compound CC(C)(C)OC(=O)NC(C)(C)CC=O VNOWIHHJPAJYHL-UHFFFAOYSA-N 0.000 description 2
• GIQHYOAEOMSKKV-SSDOTTSWSA-N tert-butyl n-[(2r)-4-oxobutan-2-yl]carbamate Chemical compound O=CC[C@@H](C)NC(=O)OC(C)(C)C GIQHYOAEOMSKKV-SSDOTTSWSA-N 0.000 description 2
• FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
• 125000005309 thioalkoxy group Chemical group 0.000 description 2
• 150000003573 thiols Chemical class 0.000 description 2
• 125000004568 thiomorpholinyl group Chemical group 0.000 description 2
• FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
• 201000002510 thyroid cancer Diseases 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 2
• GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
• UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 2
• 210000004881 tumor cell Anatomy 0.000 description 2
• 229920002554 vinyl polymer Polymers 0.000 description 2
• 239000003643 water by type Substances 0.000 description 2
• 239000001993 wax Substances 0.000 description 2
• 239000000230 xanthan gum Substances 0.000 description 2
• 229920001285 xanthan gum Polymers 0.000 description 2
• 235000010493 xanthan gum Nutrition 0.000 description 2
• 229940082509 xanthan gum Drugs 0.000 description 2
• 239000008096 xylene Substances 0.000 description 2
• XAEQIUFFBRKYDS-OAHLLOKOSA-N (2r)-2-(1,3-dioxoisoindol-2-yl)-4-oxo-4-phenylmethoxybutanoic acid Chemical compound C([C@H](C(=O)O)N1C(C2=CC=CC=C2C1=O)=O)C(=O)OCC1=CC=CC=C1 XAEQIUFFBRKYDS-OAHLLOKOSA-N 0.000 description 1
• WCZXECFPTUZDMM-YFKPBYRVSA-N (2s)-2-aminopent-4-en-1-ol Chemical compound OC[C@@H](N)CC=C WCZXECFPTUZDMM-YFKPBYRVSA-N 0.000 description 1
• XVPOTOFPQGIJRN-ZETCQYMHSA-N (3s)-3-(1,3-dioxoisoindol-2-yl)-4-fluorobutanoic acid Chemical compound C1=CC=C2C(=O)N([C@H](CF)CC(=O)O)C(=O)C2=C1 XVPOTOFPQGIJRN-ZETCQYMHSA-N 0.000 description 1
• DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
• GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 1
• 125000005988 1,1-dioxo-thiomorpholinyl group Chemical group 0.000 description 1
• OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 description 1
• VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical compound CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
• VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical compound CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 description 1
• WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
• TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
• ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
• BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
• VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
• FILKGCRCWDMBKA-UHFFFAOYSA-N 2,6-dichloropyridine Chemical compound ClC1=CC=CC(Cl)=N1 FILKGCRCWDMBKA-UHFFFAOYSA-N 0.000 description 1
• HVHZEKKZMFRULH-UHFFFAOYSA-N 2,6-ditert-butyl-4-methylpyridine Chemical compound CC1=CC(C(C)(C)C)=NC(C(C)(C)C)=C1 HVHZEKKZMFRULH-UHFFFAOYSA-N 0.000 description 1
• VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 description 1
• SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• RVHOBHMAPRVOLO-UHFFFAOYSA-N 2-ethylbutanedioic acid Chemical compound CCC(C(O)=O)CC(O)=O RVHOBHMAPRVOLO-UHFFFAOYSA-N 0.000 description 1
• YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
• VLRSADZEDXVUPG-UHFFFAOYSA-N 2-naphthalen-1-ylpyridine Chemical compound N1=CC=CC=C1C1=CC=CC2=CC=CC=C12 VLRSADZEDXVUPG-UHFFFAOYSA-N 0.000 description 1
• WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical class BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
• VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
• NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
• XMIIGOLPHOKFCH-UHFFFAOYSA-M 3-phenylpropionate Chemical compound [O-]C(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-M 0.000 description 1
• CBKDCOKSXCTDAA-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1-benzothiophene Chemical compound C1CCCC2=C1C=CS2 CBKDCOKSXCTDAA-UHFFFAOYSA-N 0.000 description 1
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
• APRZHQXAAWPYHS-UHFFFAOYSA-N 4-[5-[3-(carboxymethoxy)phenyl]-3-(4,5-dimethyl-1,3-thiazol-2-yl)tetrazol-3-ium-2-yl]benzenesulfonate Chemical compound S1C(C)=C(C)N=C1[N+]1=NC(C=2C=C(OCC(O)=O)C=CC=2)=NN1C1=CC=C(S([O-])(=O)=O)C=C1 APRZHQXAAWPYHS-UHFFFAOYSA-N 0.000 description 1
• TVSXDZNUTPLDKY-UHFFFAOYSA-N 4-isocyanatobenzonitrile Chemical compound O=C=NC1=CC=C(C#N)C=C1 TVSXDZNUTPLDKY-UHFFFAOYSA-N 0.000 description 1
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
• 208000003200 Adenoma Diseases 0.000 description 1
• 206010001233 Adenoma benign Diseases 0.000 description 1
• 208000006468 Adrenal Cortex Neoplasms Diseases 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
• 208000000058 Anaplasia Diseases 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• 206010003445 Ascites Diseases 0.000 description 1
• 241000351920 Aspergillus nidulans Species 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 108090000461 Aurora Kinase A Proteins 0.000 description 1
• 102100032311 Aurora kinase A Human genes 0.000 description 1
• 102100032306 Aurora kinase B Human genes 0.000 description 1
• 108090000749 Aurora kinase B Proteins 0.000 description 1
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
• ZGQDMWZJIAJHIT-RSXGOPAZSA-N CC(C)(C)[C@H](c1nc(-c2ccccc2)c[n]1Cc1ccccc1)N(C[C@@H](CN)F)C(N1CCNCC1)=O Chemical compound CC(C)(C)[C@H](c1nc(-c2ccccc2)c[n]1Cc1ccccc1)N(C[C@@H](CN)F)C(N1CCNCC1)=O ZGQDMWZJIAJHIT-RSXGOPAZSA-N 0.000 description 1
• IPRUHCGCSCMHCT-PXJZQJOASA-N CC(C)(C)[C@H](c1nc(-c2ccccc2)c[n]1Cc1ccccc1)N(C[C@@H](CNC(OC(C)(C)C)=O)F)C(N1CCNCC1)=O Chemical compound CC(C)(C)[C@H](c1nc(-c2ccccc2)c[n]1Cc1ccccc1)N(C[C@@H](CNC(OC(C)(C)C)=O)F)C(N1CCNCC1)=O IPRUHCGCSCMHCT-PXJZQJOASA-N 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
• 208000006029 Cardiomegaly Diseases 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
• 241000723346 Cinnamomum camphora Species 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
• 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
• 101100381659 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) bimC gene Proteins 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
• 239000005977 Ethylene Substances 0.000 description 1
• PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
• XIWZLSFPKZDWMZ-UHFFFAOYSA-N F[S](F)F.CCNCC Chemical compound F[S](F)F.CCNCC XIWZLSFPKZDWMZ-UHFFFAOYSA-N 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
• 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 229920000084 Gum arabic Polymers 0.000 description 1
• 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 241000764238 Isis Species 0.000 description 1
• 208000007766 Kaposi sarcoma Diseases 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• 206010023825 Laryngeal cancer Diseases 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 206010026673 Malignant Pleural Effusion Diseases 0.000 description 1
• NBKYPRRBTKRGLE-UHFFFAOYSA-N Maltol propionate Chemical compound CCC(=O)OC1=C(C)OC=CC1=O NBKYPRRBTKRGLE-UHFFFAOYSA-N 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 206010027406 Mesothelioma Diseases 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 208000034578 Multiple myelomas Diseases 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
• 235000009421 Myristica fragrans Nutrition 0.000 description 1
• 238000007126 N-alkylation reaction Methods 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
• JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
• ZZGOJAUAVFBXHX-AWEZNQCLSA-N O=C(C[C@@H](CF)N(C(c1c2cccc1)=O)C2=O)OCc1ccccc1 Chemical compound O=C(C[C@@H](CF)N(C(c1c2cccc1)=O)C2=O)OCc1ccccc1 ZZGOJAUAVFBXHX-AWEZNQCLSA-N 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 206010061534 Oesophageal squamous cell carcinoma Diseases 0.000 description 1
• 235000019502 Orange oil Nutrition 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 229920002230 Pectic acid Polymers 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
• 206010034811 Pharyngeal cancer Diseases 0.000 description 1
• YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
• 201000000582 Retinoblastoma Diseases 0.000 description 1
• ZICAJFMSDMCFIB-ZYRQIYSTSA-N S(=O)(=O)(OCC1=CC=CC=C1)O.N[C@@H](CC(=O)O)C Chemical compound S(=O)(=O)(OCC1=CC=CC=C1)O.N[C@@H](CC(=O)O)C ZICAJFMSDMCFIB-ZYRQIYSTSA-N 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
• 229920001800 Shellac Polymers 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 208000032383 Soft tissue cancer Diseases 0.000 description 1
• 208000036765 Squamous cell carcinoma of the esophagus Diseases 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 1
• 229940123237 Taxane Drugs 0.000 description 1
• GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
• 241000534944 Thia Species 0.000 description 1
• ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
• 229940122803 Vinca alkaloid Drugs 0.000 description 1
• 208000008383 Wilms tumor Diseases 0.000 description 1
• 241000269370 Xenopus <genus> Species 0.000 description 1
• 101000730106 Xenopus laevis Aurora kinase A-A Proteins 0.000 description 1
• 101001091264 Xenopus laevis Kinesin-like protein KIF11-B Proteins 0.000 description 1
• DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
• 235000010489 acacia gum Nutrition 0.000 description 1
• 239000000205 acacia gum Substances 0.000 description 1
• WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
• 239000012346 acetyl chloride Substances 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
• 208000009956 adenocarcinoma Diseases 0.000 description 1
• WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
• 150000001340 alkali metals Chemical class 0.000 description 1
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
• 150000001342 alkaline earth metals Chemical class 0.000 description 1
• 229930013930 alkaloid Natural products 0.000 description 1
• 125000003282 alkyl amino group Chemical group 0.000 description 1
• 150000001350 alkyl halides Chemical group 0.000 description 1
• 239000002168 alkylating agent Substances 0.000 description 1
• 229940100198 alkylating agent Drugs 0.000 description 1
• AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
• AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 239000011609 ammonium molybdate Substances 0.000 description 1
• 235000018660 ammonium molybdate Nutrition 0.000 description 1
• 229940010552 ammonium molybdate Drugs 0.000 description 1
• 210000003484 anatomy Anatomy 0.000 description 1
• 239000004037 angiogenesis inhibitor Substances 0.000 description 1
• 229940121369 angiogenesis inhibitor Drugs 0.000 description 1
• 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000000340 anti-metabolite Effects 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 229940100197 antimetabolite Drugs 0.000 description 1
• 239000002256 antimetabolite Substances 0.000 description 1
• 229940045985 antineoplastic platinum compound Drugs 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 239000008365 aqueous carrier Substances 0.000 description 1
• 239000008346 aqueous phase Substances 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• FZIZEIAMIREUTN-UHFFFAOYSA-N azane;cerium(3+) Chemical group N.[Ce+3] FZIZEIAMIREUTN-UHFFFAOYSA-N 0.000 description 1
• HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
• 229940077388 benzenesulfonate Drugs 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
• 229940050390 benzoate Drugs 0.000 description 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
• 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
• 238000005574 benzylation reaction Methods 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• XMIIGOLPHOKFCH-UHFFFAOYSA-N beta-phenylpropanoic acid Natural products OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
• 239000003124 biologic agent Substances 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 238000005415 bioluminescence Methods 0.000 description 1
• 230000029918 bioluminescence Effects 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 230000036765 blood level Effects 0.000 description 1
• 239000001045 blue dye Substances 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 125000001246 bromo group Chemical group Br* 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
• 229910052792 caesium Inorganic materials 0.000 description 1
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
• 229910000024 caesium carbonate Inorganic materials 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 229960001714 calcium phosphate Drugs 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 239000000378 calcium silicate Substances 0.000 description 1
• 229910052918 calcium silicate Inorganic materials 0.000 description 1
• 229960003340 calcium silicate Drugs 0.000 description 1
• 235000012241 calcium silicate Nutrition 0.000 description 1
• OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
• 229930008380 camphor Natural products 0.000 description 1
• 229960000846 camphor Drugs 0.000 description 1
• MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
• 125000002837 carbocyclic group Chemical group 0.000 description 1
• 150000007942 carboxylates Chemical class 0.000 description 1
• 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
• 238000005266 casting Methods 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 229920002301 cellulose acetate Polymers 0.000 description 1
• 210000003793 centrosome Anatomy 0.000 description 1
• 210000004289 cerebral ventricle Anatomy 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 229960000541 cetyl alcohol Drugs 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 239000003610 charcoal Substances 0.000 description 1
• 238000010568 chiral column chromatography Methods 0.000 description 1
• IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
• 208000006990 cholangiocarcinoma Diseases 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
• 229940001468 citrate Drugs 0.000 description 1
• 230000003021 clonogenic effect Effects 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 239000003240 coconut oil Substances 0.000 description 1
• 235000019864 coconut oil Nutrition 0.000 description 1
• 229960001338 colchicine Drugs 0.000 description 1
• 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
• 239000000084 colloidal system Substances 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
• IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
• 229960000258 corticotropin Drugs 0.000 description 1
• 235000012343 cottonseed oil Nutrition 0.000 description 1
• 239000002385 cottonseed oil Substances 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 101150085270 cut7 gene Proteins 0.000 description 1
• 201000007241 cutaneous T cell lymphoma Diseases 0.000 description 1
• 125000006165 cyclic alkyl group Chemical group 0.000 description 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• BALGDZWGNCXXES-UHFFFAOYSA-N cyclopentane;propanoic acid Chemical compound CCC(O)=O.C1CCCC1 BALGDZWGNCXXES-UHFFFAOYSA-N 0.000 description 1
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 230000032459 dedifferentiation Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 125000004663 dialkyl amino group Chemical group 0.000 description 1
• 150000008050 dialkyl sulfates Chemical class 0.000 description 1
• LMEDOLJKVASKTP-UHFFFAOYSA-N dibutyl sulfate Chemical group CCCCOS(=O)(=O)OCCCC LMEDOLJKVASKTP-UHFFFAOYSA-N 0.000 description 1
• WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
• GAFRWLVTHPVQGK-UHFFFAOYSA-N dipentyl sulfate Chemical compound CCCCCOS(=O)(=O)OCCCCC GAFRWLVTHPVQGK-UHFFFAOYSA-N 0.000 description 1
• 238000004821 distillation Methods 0.000 description 1
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical group SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
• 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
• 229940043264 dodecyl sulfate Drugs 0.000 description 1
• 238000009510 drug design Methods 0.000 description 1
• 229940112141 dry powder inhaler Drugs 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 210000001198 duodenum Anatomy 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 239000008157 edible vegetable oil Substances 0.000 description 1
• 238000000921 elemental analysis Methods 0.000 description 1
• 239000003480 eluent Substances 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 239000002702 enteric coating Substances 0.000 description 1
• 239000002532 enzyme inhibitor Substances 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 238000006735 epoxidation reaction Methods 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 208000007276 esophageal squamous cell carcinoma Diseases 0.000 description 1
• OLAMWIPURJGSKE-UHFFFAOYSA-N et2o diethylether Chemical compound CCOCC.CCOCC OLAMWIPURJGSKE-UHFFFAOYSA-N 0.000 description 1
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
• LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 1
• MQLFFYVXNZGOTC-QMMMGPOBSA-N ethyl (3s)-3-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate Chemical compound CCOC(=O)C[C@H](C)NC(=O)OC(C)(C)C MQLFFYVXNZGOTC-QMMMGPOBSA-N 0.000 description 1
• VRHAQNTWKSVEEC-UHFFFAOYSA-N ethyl 1,3-dioxoisoindole-2-carboxylate Chemical compound C1=CC=C2C(=O)N(C(=O)OCC)C(=O)C2=C1 VRHAQNTWKSVEEC-UHFFFAOYSA-N 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 210000005002 female reproductive tract Anatomy 0.000 description 1
• 239000012054 flavored emulsion Substances 0.000 description 1
• 235000020375 flavoured syrup Nutrition 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 238000003682 fluorination reaction Methods 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 235000019253 formic acid Nutrition 0.000 description 1
• 201000010175 gallbladder cancer Diseases 0.000 description 1
• 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 229940014259 gelatin Drugs 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 230000009036 growth inhibition Effects 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
• FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
• 239000008240 homogeneous mixture Substances 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 102000055595 human KIF11 Human genes 0.000 description 1
• ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• IKGLACJFEHSFNN-UHFFFAOYSA-N hydron;triethylazanium;trifluoride Chemical compound F.F.F.CCN(CC)CC IKGLACJFEHSFNN-UHFFFAOYSA-N 0.000 description 1
• PQPVPZTVJLXQAS-UHFFFAOYSA-N hydroxy-methyl-phenylsilicon Chemical class C[Si](O)C1=CC=CC=C1 PQPVPZTVJLXQAS-UHFFFAOYSA-N 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 239000000819 hypertonic solution Substances 0.000 description 1
• 238000005417 image-selected in vivo spectroscopy Methods 0.000 description 1
• MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000010874 in vitro model Methods 0.000 description 1
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
• LPAGFVYQRIESJQ-UHFFFAOYSA-N indoline Chemical compound C1=CC=C2NCCC2=C1 LPAGFVYQRIESJQ-UHFFFAOYSA-N 0.000 description 1
• HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 description 1
• 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
• 125000001041 indolyl group Chemical group 0.000 description 1
• 239000011261 inert gas Substances 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 150000007529 inorganic bases Chemical class 0.000 description 1
• 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
• 238000012739 integrated shape imaging system Methods 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 201000007450 intrahepatic cholangiocarcinoma Diseases 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 229910052740 iodine Inorganic materials 0.000 description 1
• 239000011630 iodine Substances 0.000 description 1
• 125000002346 iodo group Chemical group I* 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 230000007794 irritation Effects 0.000 description 1
• SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
• 239000012948 isocyanate Substances 0.000 description 1
• 150000002513 isocyanates Chemical class 0.000 description 1
• ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
• CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
• 206010023841 laryngeal neoplasm Diseases 0.000 description 1
• 239000010410 layer Substances 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 238000012417 linear regression Methods 0.000 description 1
• 238000004811 liquid chromatography Methods 0.000 description 1
• 239000011344 liquid material Substances 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 244000144972 livestock Species 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 208000003747 lymphoid leukemia Diseases 0.000 description 1
• 239000001115 mace Substances 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• RMGJCSHZTFKPNO-UHFFFAOYSA-M magnesium;ethene;bromide Chemical compound [Mg+2].[Br-].[CH-]=C RMGJCSHZTFKPNO-UHFFFAOYSA-M 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 229940107698 malachite green Drugs 0.000 description 1
• FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
• 210000005001 male reproductive tract Anatomy 0.000 description 1
• 239000011976 maleic acid Substances 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• JOTOUSGKSPPFQF-UHFFFAOYSA-N methyl 3-amino-3-methylbutanoate Chemical compound COC(=O)CC(C)(C)N JOTOUSGKSPPFQF-UHFFFAOYSA-N 0.000 description 1
• HUJBVSPHSJJTGK-UHFFFAOYSA-N methyl 3-amino-3-methylbutanoate;hydrochloride Chemical compound Cl.COC(=O)CC(C)(C)N HUJBVSPHSJJTGK-UHFFFAOYSA-N 0.000 description 1
• 229940095102 methyl benzoate Drugs 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 150000004702 methyl esters Chemical class 0.000 description 1
• OIRDBPQYVWXNSJ-UHFFFAOYSA-N methyl trifluoromethansulfonate Chemical compound COS(=O)(=O)C(F)(F)F OIRDBPQYVWXNSJ-UHFFFAOYSA-N 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 230000029115 microtubule polymerization Effects 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 230000011278 mitosis Effects 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 125000002757 morpholinyl group Chemical group 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 201000005962 mycosis fungoides Diseases 0.000 description 1
• 208000025113 myeloid leukemia Diseases 0.000 description 1
• 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• WOOWBQQQJXZGIE-UHFFFAOYSA-N n-ethyl-n-propan-2-ylpropan-2-amine Chemical compound CCN(C(C)C)C(C)C.CCN(C(C)C)C(C)C WOOWBQQQJXZGIE-UHFFFAOYSA-N 0.000 description 1
• AJRRXKJZYYBJPY-UHFFFAOYSA-N n-ethyl-n-propan-2-ylpropan-2-amine;trihydrofluoride Chemical compound F.F.F.CCN(C(C)C)C(C)C AJRRXKJZYYBJPY-UHFFFAOYSA-N 0.000 description 1
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
• 230000017095 negative regulation of cell growth Effects 0.000 description 1
• 230000035407 negative regulation of cell proliferation Effects 0.000 description 1
• 201000008026 nephroblastoma Diseases 0.000 description 1
• 235000001968 nicotinic acid Nutrition 0.000 description 1
• 239000011664 nicotinic acid Substances 0.000 description 1
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 231100000956 nontoxicity Toxicity 0.000 description 1
• 239000002773 nucleotide Substances 0.000 description 1
• 125000003729 nucleotide group Chemical group 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 239000010502 orange oil Substances 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 210000003463 organelle Anatomy 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 229940127084 other anti-cancer agent Drugs 0.000 description 1
• 235000006408 oxalic acid Nutrition 0.000 description 1
• 125000004043 oxo group Chemical group O=* 0.000 description 1
• 125000005254 oxyacyl group Chemical group 0.000 description 1
• 238000012856 packing Methods 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 210000004786 perivascular cell Anatomy 0.000 description 1
• JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
• 239000008177 pharmaceutical agent Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 229950000688 phenothiazine Drugs 0.000 description 1
• 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
• XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
• 229940075930 picrate Drugs 0.000 description 1
• OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
• 125000003386 piperidinyl group Chemical group 0.000 description 1
• 229950010765 pivalate Drugs 0.000 description 1
• IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 150000003058 platinum compounds Chemical class 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 229920001184 polypeptide Polymers 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
• 229910000027 potassium carbonate Inorganic materials 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1
• 102000004196 processed proteins & peptides Human genes 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 1
• VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
• 235000019260 propionic acid Nutrition 0.000 description 1
• 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
• QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
• 229960003415 propylparaben Drugs 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
• 230000000541 pulsatile effect Effects 0.000 description 1
• 239000008213 purified water Substances 0.000 description 1
• PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
• CMCFIGZTTYAYIZ-UHFFFAOYSA-N pyrrolidine-2-carbohydrazide Chemical compound NNC(=O)C1CCCN1 CMCFIGZTTYAYIZ-UHFFFAOYSA-N 0.000 description 1
• 125000000168 pyrrolyl group Chemical group 0.000 description 1
• 125000001453 quaternary ammonium group Chemical group 0.000 description 1
• 238000010791 quenching Methods 0.000 description 1
• JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
• 150000003254 radicals Chemical class 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 238000001953 recrystallisation Methods 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 238000006722 reduction reaction Methods 0.000 description 1
• 201000007444 renal pelvis carcinoma Diseases 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 230000029058 respiratory gaseous exchange Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 208000037803 restenosis Diseases 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 150000003335 secondary amines Chemical class 0.000 description 1
• 239000012056 semi-solid material Substances 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 235000013874 shellac Nutrition 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 208000000649 small cell carcinoma Diseases 0.000 description 1
• 201000002314 small intestine cancer Diseases 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
• 239000011343 solid material Substances 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 235000010356 sorbitol Nutrition 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 125000003003 spiro group Chemical group 0.000 description 1
• 206010041823 squamous cell carcinoma Diseases 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 230000000707 stereoselective effect Effects 0.000 description 1
• 239000012058 sterile packaged powder Substances 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 125000004434 sulfur atom Chemical group 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 229940095064 tartrate Drugs 0.000 description 1
• YEBDZDMYLQHGGZ-UHFFFAOYSA-N tert-butyl 2,5-dihydropyrrole-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CC=CC1 YEBDZDMYLQHGGZ-UHFFFAOYSA-N 0.000 description 1
• GIQHYOAEOMSKKV-ZETCQYMHSA-N tert-butyl n-[(2s)-4-oxobutan-2-yl]carbamate Chemical compound O=CC[C@H](C)NC(=O)OC(C)(C)C GIQHYOAEOMSKKV-ZETCQYMHSA-N 0.000 description 1
• BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
• 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 150000003512 tertiary amines Chemical class 0.000 description 1
• CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 1
• 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
• QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
• 125000003831 tetrazolyl group Chemical group 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 231100001274 therapeutic index Toxicity 0.000 description 1
• 125000001544 thienyl group Chemical group 0.000 description 1
• 229930192474 thiophene Natural products 0.000 description 1
• 125000000464 thioxo group Chemical group S=* 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 239000012049 topical pharmaceutical composition Substances 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• 230000037317 transdermal delivery Effects 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 208000029387 trophoblastic neoplasm Diseases 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 230000002485 urinary effect Effects 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 229960005486 vaccine Drugs 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 230000028973 vesicle-mediated transport Effects 0.000 description 1
• 229960003048 vinblastine Drugs 0.000 description 1
• JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
• 238000006886 vinylation reaction Methods 0.000 description 1
• 238000012800 visualization Methods 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 150000003722 vitamin derivatives Chemical class 0.000 description 1
• 238000010792 warming Methods 0.000 description 1
• 238000005303 weighing Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1